Evidence | Glytec

Transitioning Safely from Intravenous to Subcutaneous Insulin

Feb 10, 2022

Publication Current Diabetes Reports Date March 2015 Authors Kathryn Evans Kreider, Lillian F. Lien Abstract The transition from intravenous (IV) to subcutaneous (SQ) insulin in the hospitalized patient with diabetes or hyperglycemia is a key step in patient care....

Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia

Nov 22, 2021

Publication Journal of Diabetes Science and Technology Date June 23, 2021 Authors David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE1, Jordan Messler, MD, SFHM, FACP2, Timothy Valk, MD, FACP, FACE3, Ram Jagannathan,...

The Power of Inpatient Glucometrics

Aug 12, 2021

Presentation Association of Diabetes Care & Education Specialists Annual Conference 2021 Date August 12th, 2021 Authors Jordan Messler, MD, SFHM, FACP, Kerri Doucette, BSN, RN, RDN, CDCES WHY DATA MATTERS Change is hard: data can make it easier Can’t...

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools

Jun 25, 2021

Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2021 Authors Bruce Bode, MD, FACE¹, John Clarke, RN, CDCES², Jordan Messler, MD, SFHM, FACP², Robert Booth, CPHQ² AUTHOR AFFILIATIONS ¹Atlanta Diabetes Associates, Atlanta, GA, USA, ²Glytec,...

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA

Jun 25, 2021

Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2020 Authors Jordan Messler, MD, SFHM, FACP¹, Priyathama Vellanki, MD², Bruce Bode, MD, FACE³, John Clarke RN, CDCES¹, Robert Booth, CPHQ¹ Author Affiliations ¹Glytec, Waltham, MA, USA, ²Emory...